Journal of Applied Bioanalysis will be publishing a specially focused issue dedicated to Microsampling in Bioanalysis: Opportunities and Challenges in the era of the COVID-19 pandemic. The Journal of Applied Bioanalysis invites the submission of abstracts on topics related to the special issue topic. Abstract proposals will be used to select and invite papers for final review and consideration.
Special Issue Editor
Rohitash Jamwal Ph.D.
Agios Pharmaceuticals, Cambridge, MA, USA.
Bioanalysis holds a key role in drug discovery and development process. COVID-19 crisis has provided a push to patient-centric technologies and microsampling is one such rapidly evolving technology that demands attention of the bioanalytical community. Given that microsampling is still in its early stages of acceptance in pharmaceutical industry, there exists an opportunity to share rapidly evolving landscape of its application in industry, academia and contract research organizations.
Adoption of new technologies in bioanalysis is complex and challenging. Microsampling presents an attractive alternative to conventional sampling in special populations such as children, neonates or patients with critical illness. The ease of at home sampling can also enable studies in patients with limited access to clinical labs. This special issue is aimed to bring forward and summarize the current state, opportunities and challenges of microsampling based technologies across pharmaceutical industry, contract research organizations and academia. The manuscripts will address important issues ranging from development and implementation of microsampling technologies for quantification of small molecules, antibodies and biomarkers.
Aims and Scope
We invite the authors to submit the manuscripts for a special issue of the Journal of Applied Bioanalysis focused on microsampling encompassing the recent advances in the field and novel findings in experimental methods/protocols.
This special issue will focus on the technological and theoretical developments in the microsampling field. It will help the journal’s mission to cover various articles on multiple features of bioanalytical methods, techniques, philosophy, and advancement in instrumentation.
We welcome a wide range of manuscripts like novel methodologies, review articles, or original research.
We welcome the submission of manuscripts on following topics (but not limited to):
Authors are encouraged to submit the articles of various types including Review, Original Research – describing novel cases of gene regulation or methods describing advances in protocols, Opinion, Expert Communication, Rapid Communication, Special Reports, Letters-to-the-Editor, and Application Notes.
The manuscripts in this special issue may cover, but are not limited to, the following topics:
- Microsampling in non-clinical analysis
- Microsampling in clinical analysis
- Microsampling in Small molecule and antibodies analysis
- Microsampling in Biomarker analysis
- Microsampling in Toxicological analysis
- Microsampling in COVID-19 infection
- Therapeutic drug monitoring
- Novel microsampling techniques, tools, and instrumentation
- Workflow and sample preparation automation
- Logistic and regulatory hurdles
- Social and patient impact
Manuscripts submitted, however not accepted for publication in this specially focused issue, but meeting all required publication standards of the Journal of Applied Bioanalysis, will be published in a regular journal issue.
can be downloaded here.
The timeline for this special focused issue is as follows:
- Manuscript submission deadline: 15 July 2021
- Peer Review Due: August 2021
- Revision Due: September 2021
- Final manuscripts due: September 2021
- Publication online: October 2021
Open Access Manuscript Fees
All content of the Journal of Applied Bioanalysis is free accessible (open access). There are Article Processing Charges (APC) for this special focused issue of € 370.
For scientists with limited financial funds, a (partial) waive of APC is possible when he/she can prove this limitation. For more information on APC waivers, see here
Dr. Roland J.W. Meesters, Editor-in-Chief Journal of Applied Bioanalysis; email@example.com